Connect with us

Health

Cara Therapeutics Inc (NASDAQ:CARA) Closes In Red

Published

on

In the last trading session, the stock price of Cara Therapeutics Inc (NASDAQ:CARA) declined more than 1% to close the day at $12.60. The decline came at a share volume of 658,379 compared to average share volume of 807,744. A new study performed by experts at the University of New Mexico, involving prescription opioid and medical cannabis use among people suffering with chronic pain, showed a distinct link between having the legal knack to use cannabis and major reductions in opioid use.

The details

Cannabinoids seen in the marijuana crop, cannabidiol is the phyto-cannabinoid with probably the greatest potential for advancement as a therapeutic plan for substance use disorders. In an article by experts at Mt. Sinai School of Medicine indicates to animal models that put forward Hemp, found in cannabis, might lower opioid-seeking behavior and withdrawal symptoms. Active in the markets include Perrigo Company PLC (NYSE:PRGO), VERITAS PHARMA ORD (OTCMKTS:VRTHF), and Cara, to name a few.

Cara Therapeutics closed down slightly on Tuesday at $12.60. The company is a clinical-stage biopharmaceutical entity with its main focus on advancing and commercializing state-of-the-art chemical entities intended to alleviate pruritus and pain by selectively targeting peripheral KORs. It is developing a proprietary and novel class of offerings, led by CR845. The candidate has shown initial efficacy in people with moderate-to-severe pain, without resulting several of the undesirable side effects usually associated with presently available opioid pain therapeutics in the market.

Veritas Pharma reported that its research unit, Cannevert Therapeutics Ltd. has finalized a letter of intent with the FDI in San Juan, to conduct the preliminary human study of CTL-X, its major cannabis strain targeting pain. The trial will be performed in two stages to evaluate the analgesic effects of the lead strain. The initial stage will constitute an open label design to assess the feasibility of two doses of “CTL-X” in five subjects while the next stage will use a double-blind, randomized, crossover design to evaluate one dose of CTL-X versus a placebo control strain in sixteen people who will be exposed to different modalities of acute pain.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of MMJReporter.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement

Title

Uncategorized3 days ago

Top 15 Essential Oils + Health Benefits

Top 15 Essential Oils + Health Benefits Each and every essential oil contains compounds with unique healing and therapeutic benefits....

Uncategorized3 days ago

Using Hemp Oil in Cooking

Hemp oil has many advocates. The oil from hemp seeds is rich in omega-3 and omega-6 essential fatty acids. This makes...

Uncategorized7 days ago

Best Oil Producers of 2018

Millionaires are being made by the moment in the medical marijuana industry. Venture capital firms, private equity firms, and even...

MyDx Inc MyDx Inc
Health3 weeks ago

MyDx Inc. (OTCMKTS:MYDX) Initiates Clinical Trial of Cannabis Formula for The Treatment of Chronic Low Back Pain

San Diego, CA based MyDx Inc. (OTCMKTS:MYDX) has announced the controlled trial of the cannabis formula for the treatment of...

Business3 weeks ago

Fastfunds Financial Corporation (OTCMKTS:FFFC) Is All Set to Launch Affinity Connextions Program Targeting MMJ Industry

Fastfunds Financial Corporation (OTCMKTS:FFFC) has announced the completion of all necessary formalities to introduce an Affinity Connextions Program through a...

Innovative Industrial Properties Inc Innovative Industrial Properties Inc
Business3 weeks ago

Innovative Industrial Properties, Inc (NYSE:IIPR) Unveils Exercise Of Underwriter’s Option To Purchase Common Stock Shares

Innovative Industrial Properties, Inc (NYSE:IIPR) announced recently that it has obtained the exercise of the underwriter’s option to buy additional...

Business3 weeks ago

Next Generation Management Corporation (OTCMKTS:NGMC) Updates On New Medical Marijuana System in Oregon

Nextgen Holdings, a subsidiary of the Next Generation Management Corporation (OTCMKTS:NGMC) recently updated its stockholders with the ongoing Medical Marijuana...

INDUSTRIAL HEMP3 weeks ago

Weed Inc’s (OTCMKTS:BUDZ) Performance Is Getting Higher

Weed Inc (OTCMKTS:BUDZ) has for a long time been enjoying the momentous highs for the past few months. The company’s...

INDUSTRIAL HEMP3 weeks ago

Namaste Technologies Inc (OTCMKTS:NXTTF) Signs A Share Purchase Agreement With Cannbit Ltd

Namaste Technologies Inc (OTCMKTS:NXTTF) announced recently that it signed a non-binding Letter of Intent (LOI) with Cannabit Limited where the...

INDUSTRIAL HEMP3 weeks ago

MariMed Inc. (OTCMKTS:MRMD) Plans To Expand Its Cannabis Business

MeriMed Inc. (OTCMKTS:MRMD) announced its grand plans to expand business into the emerging cannabis industry. Furthermore, the company intends to...

Advertisement
Advertisement
Advertisement